sla models
General Info
Hepatitis B Symposium Hepatitis C Symposium

During the last years it has been a practice that Invited Speakers register online. It is not mandatory, but rather an altruistic personal contribution to sponsor the participation of Delegates that otherwise would not have the necessary funds to attend the meeting. We thank in advance all Invited Speakers for registering online.

Speakers for the Hepatitis B Symposium:
Speaker Title Institution Country
Akbar Sheikh Mohammad Fazle Akbar, PhD Designing Evidence-based Immune Therapy for Chronic HBV infection and beyond. Toshiba General Hospital japan
  Trepo Christian Trepo, MD, PhD Pending title Head of the Internal Medicine Department and Head of the Hepato-Gastroenterology Department CHU de Lyon HCL - GH Nord-Hôpital de la Croix Rousse france
  Pavel Bogomolov, Prof. Epidemiology and therapeutic approaches to the treatment of Chronic Hepatitis B and C in Russia. Generium Russia
  Nelson Nelson Cheinquer, PhD GILEAD HBV therapy approaches Gilead  Bra
  XY Wang, PhD Antigen-antibody complex based therapeutic hepatitis B vaccine Institutes of Biomedical Sciences, Fudan University, Shanghai China
  Bin Wang, PhD Use of GM-CSF as A Therapeutic Vaccine Adjuvant to Treat Chronic in HBV infection. China
Wang Guiqiang, PhD Pending title China
Fu-Sheng Wang, PhD Pending title Treatment and Research Center for Infectious Diseases, Beijing Hospital China
  Michalak Thomas Michalak, PhD. Distinct forms of hepadnavirus infection associated with the developmentof hepatocellular carcinoma in the woodchuck model of hepatitis B Molecular Virology and Hepatology Research Group, Memorial University Canada
  JCA Julio C, Aguilar, PhD. HeberNasvac therapeutic vaccine: from bench to CT CIGB, Havana Cuba
  Mamun Mamun al Matabh, PhD. From Nasvac to HeberNasvac: A Journey across seven seas Bangabandhu Sheikh Mujib Medical University Bangladesh
zurina Zurina Cinza, MD. Clinical trials with HeberNasvac in Cuba: Phase I and CIGB, Havana Cuba

Speakers for the Hepatitis C Symposium:
Speaker Title Institution Country
Michalak Thomas Michalak, PhD. Expression of IFNs and IFN-Associated Genes in Immune Cells in Persistent Hepatitis C Virus Infections Molecular Virology and Hepatology Research Group, Memorial University Canada
Farzin Farzin Roohvand, PhD The Rise of the new Era in HCV vaccine studies General Virology Department, Pasteur Institute of Iran  iran
Aboushousha, T, M.D., PhD Differential expression of glypican 3 and insulin-like growth factor-II mRNAs in liver tissues of hepatocellular carcinoma on top of HCV cirrhosis Pathology Department, Theodor Bilharz Research Institute, Cairo USA
Arash Arash Grakoui, PhD Pending Title Division of Infectious Diseases, Emory University School of Medicine USA
  Gillian Martinez, PhD. Hepatitis c vaccine based on HCV quimeric protein CIGB, Havana Cuba
  Alberto Alberto Moriggia , MD Hepatitis C Therapy in People who inject drugs: from Interferon to DAAs Epatocentro Ticino Liver Clinic, Lugano Swi
CIGB 30 Aniv
Center for Genetic Engineering and Biotechnology, Havana, Cuba
address 31 Ave e/ 158 and 190, Cubanacan, Playa, Havana 10600, Cuba
phone (53-7) 250 4559
(53-7) 271 6022 7421 ext.1140